Provided by Tiger Trade Technology Pte. Ltd.

Bluejay Diagnostics Inc

1.01
-0.0200-1.94%
Pre-market: 0.9602-0.0498-4.93%05:58 EDT
Volume:1.45M
Turnover:1.43M
Market Cap:4.51M
PE:-0.15
High:1.08
Open:1.01
Low:0.8900
Close:1.03
52wk High:16.68
52wk Low:0.8180
Shares:4.47M
Float Shares:4.38M
Volume Ratio:0.15
T/O Rate:33.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6477
EPS(LYR):-15.2513
ROE:-98.89%
ROA:-51.08%
PB:0.48
PE(LYR):-0.07

Loading ...

Bluejay Diagnostics expands federal access via Lovell partnership

TIPRANKS
·
Yesterday

Bluejay Diagnostics and Lovell Government partner to access federal healthcare

TIPRANKS
·
Sep 08

Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets

THOMSON REUTERS
·
Sep 08

Bluejay Advances Symphony Platform, Strengthens Cash Position

TIPRANKS
·
Aug 13

Bluejay Diagnostics Q2 EPS $(1.12) Up From $(5.64) YoY

Benzinga Earnings
·
Aug 13

Bluejay Diagnostics Says SYMON-II Pivotal Study Completes Enrollment of 750 Patients for Symphony IL-6 Test

Reuters
·
Aug 13

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ Il-6 Toward Regulatory Submission and Commercialization

THOMSON REUTERS
·
Aug 13

Press Release: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony(TM) IL-6 Toward Regulatory Submission and Commercialization

Dow Jones
·
Aug 13

Bluejay Net Loss Widens to $2.32 Million in Q2 FY26

Reuters
·
Aug 13

Top Premarket Gainers

MT Newswires Live
·
Aug 05

Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study

TIPRANKS
·
Jul 23

Bluejay Diagnostics Initial Beneficial Ownership Statement Names Bank of America as 10% Owner

Reuters
·
Jul 23

Bluejay Diagnostics completes enrollment in SYMON-II study

TIPRANKS
·
Jul 21

Bluejay Diagnostics Announces Symon-ii Sepsis Study Enrollment Completion

Reuters
·
Jul 21

Bluejay Diagnostics - Preliminary Symon-ii Data Show 17% 28-day Mortality Rate

THOMSON REUTERS
·
Jul 21

Bluejay Diagnostics Announces Successful Completion of Enrollment in the Symon-ii Multicenter Clinical Validation Study

THOMSON REUTERS
·
Jul 21

HRT Financial LP Sells 34,938 Bluejay Diagnostics Shares for $48,913.20

Reuters
·
Jul 14

Bluejay Diagnostics Initial Beneficial Ownership Filing Shows HRT Financial LP Stake of 126,993 Shares

Reuters
·
Jul 14

Bluejay Diagnostics Advances Symphony IL-6 Sepsis Pilot, Keeping Investor Focus on ER Diagnostics

TIPRANKS
·
Jul 03

Bluejay Diagnostics files to sell 11.22M shares of common stock for holders

TIPRANKS
·
Jun 18